Budesonide bests COVID-19

[摘要] What is the effect of inhaled corticosteroids onlength of illness, emergency department visits, andhospital admissions in outpatients with COVID-19?Bottom lineBased on 2 open-label trials, higher-risk outpatients (≥1 comorbidity) with suspected or confirmed COVID-19 may benefit from 800 µg of inhaledbudesonide twice a day for 14 days. Compared withusual care, budesonide shortened the time to recovery (12 vs 15 days), increased the proportion ofpatients recovering by day 14 (32% vs 22%), andreduced the need for health services (53% vs 59%).

[学科分类] 卫生学